Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C40H57N5O7 |
Molecular Weight | 719.9099 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4
InChI
InChIKey=BLMPQMFVWMYDKT-NZTKNTHTSA-N
InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1
Molecular Formula | C40H57N5O7 |
Molecular Weight | 719.9099 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:54:47 UTC 2023
by
admin
on
Fri Dec 15 15:54:47 UTC 2023
|
Record UNII |
72X6E3J5AR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
795120
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
||
|
NDF-RT |
N0000175604
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
||
|
FDA ORPHAN DRUG |
252507
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
||
|
WHO-VATC |
QL01XX45
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
KYPROLIS (AUTHORIZED: MULTIPLE MYELOMA)
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/08/548
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
||
|
WHO-ATC |
L01XX45
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
||
|
NCI_THESAURUS |
C2160
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C52196
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
Carfilzomib
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
65347
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
8859
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
868540-17-4
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
72X6E3J5AR
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
72X6E3J5AR
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
C524865
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
SS-92
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
758252
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
m3107
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | Merck Index | ||
|
DB08889
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
1302966
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000126282
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
SUB32911
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
Carfilzomib
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
DTXSID4048690
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
4483
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
7420
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
CHEMBL451887
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY | |||
|
11556711
Created by
admin on Fri Dec 15 15:54:47 UTC 2023 , Edited by admin on Fri Dec 15 15:54:47 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
TRANSPORTER -> INHIBITOR |
WEAK
|
||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR | |||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA; URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
Cytochrome P450-mediated mechanisms played a minor role in overall carfilzomib metabolism
MAJOR
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||